Drug Information Analysis Service

Abstract

Get full access to this article

View all access options for this article.

References

Fairshter

Hubib

Wilson

. Inhaled atropine sulfate in acute asthma. Respiration 1981; 42: 263–72.

Cavanaugh

Cooper

. Inhaled atropine sulfate: Dose response characteristics. Am Rev Respir Dis 1976: 114: 517–24.

Cropp

GJA

. The role of the parasympathetic system in the maintenance of chronic airway obstruction in asthmatic children. Am Rev Respir Dis 1975; 112: 599–605.

Hemstreet

MPB

. Atropine nebulization—safe and simple. Ann Allergy 1980; 44: 138–41.

Klock

Miller

Morris

Watanabe

Dickman

A comparative study of atropine sulfate and isoproterenol hydrochloride in chronic bronchitis. Am Rev Respir Dis 1975; 112: 371–6.

Austin

. Reversibility of airway obstruction in chronic bronchitis. Clin Sci 1972; 42: 725–33.

Marini

Lakshminarayan

The effect of atropine inhalation in “irreversible” chronic bronchitis. Chest 1980; 77: 591–6.

Pak

Kradjan

Lakshminarayan

Marini

Inhaled atropine sulfate: Dose response characteristics in adult patients with chronic airflow obstruction. Am Rev Respir Dis 1982; 125: 331–4.

Larsen

Baron

Cotton

Brooks

. A comparative study of inhaled atropine sulfate and isoproterenol hydrochloride in cystic fibrosis. Am Rev Respir Dis 1979; 119: 399–407.

10.

Butler

Caro

Alcala

Dubois

. Physiological factors affecting airway resistance in normal subjects and patients with obstructive respiratory disease. J Clin Invest 1960; 30: 584–91.

11.

Crompton

. A comparison of response to bronchodilator drugs in chronic bronchitis and chronic asthma. Thorax 1968; 23: 45–55.

12.

Beakey

Bresnick

Levison

Segal

. Evaluation of therapeutic substances employed for the relief of bronchospasm. III. Anticholinergic agents. Ann Allergy 1949; 7: 113–21.

13.

Zimet

Respiratory pharmacology. Philadelphia: WB Saunders Co. 1978: 125.

14.

Cockcroft

Killian

Mellon

Jja

Hargreave

. Protective effect of drugs on histamine-induced asthma. Thorax 1977; 32: 429–37.

15.

Peerless

Raechelefsky

Mickey

Katz

Siegel

. Bronchodilator characteristics of nebulized metaproterenol sulfate, isoetharine and atropine in chronic asthma. J Allergy Clin Immunol 1983; 72: 702–8.

16.

Marini

Lakshmirayan

Kradjan

. Atropine and terbutaline aerosols in chronic bronchitis: Efficacy and sites of action. Chest 1981; 80: 285–91.

17.

Shenfield

. Combination bronchodilator therapy. Drugs 1982; 24: 414–39.

18.

Brady

Easton

. The value of atropine in the documentation of reversible airways obstruction. Ann Allergy 1979; 42: 211–7.

19.

Passamonte

Martinez

. Effects of inhaled atropine or metaproterenol in patients with chronic airways obstruction and therapeutic theophylline levels. Chest 1984; 85: 610–4.

20.

Lyell

Toxic epidermal necrolysis: An eruption resembling scalding of the skin. Br J Dermatol 1956; 68: 355–61.

21.

Fritsch

Elias

. Toxic epidermal necrolysis. In: Fitzpatrick

Eisen

Wolff

, eds. Dermatology in general medicine. New York: McGraw Hill, 1979: 303–6.

22.

Amon

Diamond

. Toxic epidermal necrolysis: Rapid differentiation between staphylococcal- and drug-induced disease. Arch Dermatol 1975; 111: 1433–7.

23.

Elias

Fritsch

. Staphylococcal scalded-skin syndrome. In: Fitzpatrick

Eisen

Wolff

, eds. Dermatology in general medicine. New York: McGraw Hill, 1979: 306–10.

24.

Scully

Galdabini

McNeely

, eds. Acute onset of erythematous rash with bullae in a 27-year-old woman. Case records of the Massachusetts General Hospital. N Engl J Med 1978; 299: 33–9.

25.

Demling

Suellyn

Lower

. Burn unit management of toxic epidermal necrolysis. Arch Surg 1978; 113: 758–9.

26.

Montgomery

. Toxic epidermal necrolysis due to phenylbutazone (letter). Br J Dermatol 1970; 83: 220.

27.

Ruiz-Maldonado

Naguezprieto

. Toxic epidermal necrolysis (Lyells' syndrome) and delayed action sulfonamides. Bol Med Hosp Infant Mex 1974; 88: 1201–10.

28.

Almeyola

Levantine

Drug Reactions SVII. Cutaneous reactions to barbiturates, chloral hydrate and its derivatives. Br J Dermatol 1972; 86: 313–6.

29.

Stittgen

Toxic epidermal necrolysis provoked by barbiturates. Br J Dermatol 1973; 88: 291–3.

30.

Nozickova

Danda

Hamakova

, Toxic epidermal necrolysis—Lyells' syndrome in a patient protractedly treated by anti-epileptic agents. Cesk Dermatol 1976; 51: 375–9.

31.

Gately

Lam

. Phenytoin-induced toxic epidermal necrolysis. Ann Intern Med 1979; 91: 59–60.

32.

Tagami

Tatsuta

Iwatski

Yamada

Delayed hypersensitivity in ampicillin induced toxic epidermal necrolysis. Arch Dermatol 1983; 119: 910–3.

33.

Sehgal

Bahadur

Ghosh

SK.

, Toxic epidermal necrolysis as a result of anti-tubercular drugs. Indian J Chest Dis Allied Sci 1973; 15: 57–60.

34.

Kantor

. Toxic epidermal necrolysis, azotemia and death after allopurinol therapy. JAMA 1970; 212: 478–9.

35.

Stratigos

Bartsokas

Capetanakis

Further experiences of toxic epidermal necrolysis incriminating allopurinol, pyrazolone and derivatives. Br J Dermatol 1972; 86: 564–7.

36.

Hennemann

Hubertus

Stocker

. Severe side effects of treatment with D-penicillamine. Dtsch Med Wochenschr 1975; 100: 1634–8.

37.

Bedi

Singh

Bhutani

. Acute epidermal necrolysis (Lyell syndrome) induced by thiacetazone. Indian J Chest Dis Allied Sci 1974; 16: 55–7.

38.

Hunter

Davison

. Toxic epidermal necrolysis associated with pentazocine therapy and severe reversible renal failure. Br J Dermatol 1973; 88: 287–90.

39.

Levitt

Pearson

. Sulindac-induced Stevens-Johnson toxic epidermal necrolysis syndrome. JAMA 1980; 243: 1262–3.

40.

Feldman

Lambert

Parke

Toxic epidermal necrolysis in a patient treated with gold salts and benoxaprofen. Rheumatol Rehabil 1982; 21: 222–4.

41.

Reed

Saber

. Methotrexate-induced necrolysis. J Am Acad Dermatol 1983; 8: 677–9.

42.

Yaffee

Grots

Ecdysis secondary to 5-fluorouracil. Cutis 1980; 25: 649–50.

43.

Camisa

Grines

Amoxapine: A cause of toxic epidermal necrolysis? (letter) Arch Dermatol 1983; 119: 709–10.

44.

Breathnach

McGibbon

Ive

Black

. Carbamazepine and toxic epidermal necrolysis: Report of three cases with histopathological observations. Clin Exp Dermatol 1982; 7: 585–91.

45.

Rodriguez

. L-asparaginase and toxic epidermal necrolysis. J Med Assoc Ga 1980; 69: 355–7.

46.

Purpura

Ahern

Silverman

Toxic epidermal necrolysis after mithramycin (letter). N Engl J Med 1978; 299: 1412.

47.

Callaway

Tate

. Toxic epidermal necrolysis caused by gin and tonic (quinine) (letter). Arch Dermatol 1974; 109: 909.

48.

O'Sullivan

Hanly

Molloy

A case of toxic epidermal necrolysis secondary to indomethacin. Br J Rheumatol 1983; 22: 47–9.

49.

Czarnickl

Czubak

Traczyk-Hartleb

Lyell's toxic epidermal necrolysis after smallpox vaccination. Pol Tyg Lek 1970; 25: 982–3.

50.

Shaa

Rayhanzadeh

Toxic epidermal necrolysis following measles vaccination. Arch Dermatol 1974; 110: 559–62.

51.

Sala

Crosti

Monti

Dibitonto

Cutaneous pathology due to captopril: Observations on 2 clinical cases. G Ital Dermatol Venereol 1983; 118: 89–93.

52.

Pegram

Mountz

O'Bar

. Ethambutol-induced toxic epidermal necrolysis. Arch Intern Med 1981; 141: 1677–8.

53.

Maddocks

Slater

. Toxic epidermal necrolysis, agranulocytosis and erythroid hypoplasia associated with sulfasalazine. J R Soc Med 1970; 73: 587–8.

54.

Jain

Mathur

Shukla

Gupta

. Toxic epidermal necrolysis (Lyell's syndrome) due to streptomycin. Indian J Chest Dis Allied Sci 1980; 22: 73–6.

55.

Randell

Tolvon and toxic epidermal necrolysis (letter). Med J Aust 1979; 2: 653.

56.

Robinson

Samorodin

. Thiabendazole-induced toxic epidermal necrolysis. Arch Dermatol 1976; 112: 1757–60.

57.

Wang

Freeman

Gaeta

JF.

, Unusual complications of pentamidine in the treatment of Pneumocystis carinii pneumonia. J Pediatr 1970; 77: 311–4.

58.

Gardarini

Valassina

. Report of case of Lyell's syndrome during a course of treatment with matulane. Minerva Med 1973; 64: 2775–8.

59.

Dabadie

Lamouliatte

Quinton

Geniaux

Lyell's syndrome induced by cimetidine. Gastroenterol Clin Biol 1983; 7: 425–6.

60.

Petersen

Kastrup

Bartram

Toxic epidermal necrolysis: A case caused by sulfamethoxazole combined with trimethoprim. Ugesk Laeger 1983; 145: 3345–6.

61.

Andriushchenko

Lamber

. Case of Lyell's syndrome developing after the intramuscular administration of vitamin B-6. Klin Med 1980; 58: 101–2.

62.

Zeile

Wandel

Bork

Kronig

Lyell's syndrome with transient bone marrow depression caused by oxyphenbutazone. MMW 1979; 121: 949–52.

63.

Bruikhanova

Privalova

. Lyell's syndrome following vaccination with diphtheria-pertussis-tetanus vaccine in a 9 month old child. Pediatriia 1979; 12: 60–1.

64.

Mathé

Aubert

Labouche

, Syndrome of Lyell. Etiologie médicamenteuse: Role probable due chloramphénicol (letter). J Med Bordeaux 1965; 142: 1367.

65.

Stern

Bigby

An expanded profile of cutaneous reactions to nonsteroidal anti-inflammatory drugs. JAMA 1984; 252: 1433–7.

66.

Rienhoff

., ed. Toxic epidermal necrolysis. The Johns Hopkins Med J 1982; 151: 326–31.

67.

Schmidt

Kluge

Fatal toxic epidermal necrolysis following reexposure to phenytoin: A case report. Epilepsia 1983; 24: 440–3.

68.

Lyell

Review of toxic epidermal necrolysis in Britain. Br J Dermatol 1967; 79: 662–71.

69.

Bjornberg

Fifteen cases of toxic epidermal necrolysis (Lyell). Acta Derm Venereol (Stockh) 1973; 53: 149–52.

70.

Ortiz

Horn

Peterson

. Toxic epidermal necrolysis: Case report and a review of the literature. Ann Plast Surg 1982; 9: 249–53.

71.

Rasmussen

. Toxic epidermal necrolysis. In: Maddin

, ed. Current dermatologie therapy. Philadelphia: W.B. Saunders, 1979: 465–6.

72.

Bluestone

Shurin

. Middle ear disease in children. Ped Clin North Am 1974; 21: 377–97.

73.

Sloyer

Ploussard

Homie

. Efficacy of pneumococcal polysaccharide vaccine in preventing acute otitis media in infants in Huntsville, Alabama. Rev Infect Dis 1981; 3 (suppl): 119–23.

74.

Makela

Leinonen

Pukander

, A Study of the pneumococcal vaccine in prevention of clinically acute attacks of recurrent otitis media. Rev Infect Dis 1981; 3 (suppl): 124–30.

75.

Teele

Kelin

Bratton

, Use of pneumococcal vaccine for prevention of recurrent acute otitis media in infants in Boston. Rev Infect Dis 1981; 3 (suppl): 113–8.

76.

Schuller

Prophylaxis of otitis media in asthmatic children. Pediatr Infect Dis 1983; 2: 280–3.

77.

Karma

Luotonen

Timonen

, Efficacy of pneumococcal vaccination against recurrent otitis media: Preliminary results of a field trial in Finland. Ann Otol Rhino Laryngol 1980; 89 (suppl 68): 357–62.

78.

Giebink

Berzins

IK.

Quie

. Animal models for studying pneumococcal otitis media and pneumococcal vaccine efficacy. Ann Otol Rhinol Laryngol 1980; 89 (suppl 68): 339–42.

79.

Giebink

Schiffman

Petty

Quie

. Modification of otitis media following vaccination with the capsular polysaccharide of Streptococcus pneumoniae in chinchillas. J Infect Dis 1978; 138: 480–7.

80.

Teele

Klein

Rosner

. Epidemiology of otitis media in children. Ann Otol Rhinol Laryngol 1980; 89 (suppl 68): 5–6.

81.

Douglas

Paton

Duncan

Hansman

. Antibody response to pneumococcal vaccination in children younger than 5 years of age. J Infect Dis 1983; 148: 131–7.

82.

Cowan

Amman

Wara

DW.

, Antibody response to pneumococcal vaccination in children younger than 5 years of age. Pediatrics 1978; 62: 721–7.

83.

Sell

Uright

Vaughn

SK.

, Clinical studies of pneumococcal vaccines in infants: Reactogenicity and immunogenicity of two polyvalent polysaccharides vaccines. Rev Infect Dis 1981; 3 (suppl): 97–107.

84.

An expanded pneumococcal vaccine. Med Lett 1983; 25: 91–2.

85.

Update: Pneumococcal polysaccharide vaccine usage—United States. MMWR 1984; 33: 273–81.